Trials / Terminated
TerminatedNCT00535821
Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock
A Multi-center Randomized Comparison of a Minimally-invasive Cardiovascular Hemodynamic Optimization (MiCHO) Protocol Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock Patients Presenting to the Emergency Department
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Early intervention in the treatment of septic shock, including early goal-directed therapy (EGDT) in the first 6 hours of disease presentation, has been shown to significantly decrease mortality. However, this approach requires invasive hemodynamic monitoring, thus limiting its widespread application in the emergency department setting. A minimally invasive protocol utilizing esophageal Doppler monitoring (EDM) may be of benefit and practical if it is shown to result in similar outcome as EGDT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Esophageal Doppler monitoring - CardioQ, Deltex Inc | 6-hour hemodynamic optimization of severe sepsis or septic shock guided by EDM |
| DEVICE | Central line with CVP and continuous ScvO2 monitoring | 6-hour hemodynamic optimization of severe sepsis or septic shock guided by CVP and ScvO2 monitoring |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2007-09-26
- Last updated
- 2014-06-25
- Results posted
- 2014-06-25
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00535821. Inclusion in this directory is not an endorsement.